Verve Therapeutics VERV 深 沪
已收盘 07-25 16:00:00 美东时间
11.13
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 11.13
- 总市值 9.94亿
- 52周最高 11.405
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 2.8647
- 委 比 0.00%
- 总股本 8931.22万
- 历史最高 78.00
- 量 比 0
- 振 幅 0.00%
- 历史最低 2.8647
- 每 手 1
- 风险率 2.08%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多For The FY 2025, Broadwind Expects Revenues In A Range Of $145M To $155M
CICERO, Ill., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Broadwind (NASDAQ:BWEN, or the "Company"))), a diversified precision manufacturer of specialized components and equipment serving global markets, today announced the
09-11 04:22
扎根兴安盟！申菱中标“职工之家+少年乐园+体育主场”综合楼，助力北疆文化体育事业...
资讯速递 NEWS EXPRESS 随着兴安盟工人文化宫、青少年体育活动中心及乌兰浩特市少年宫综合楼项目调试完成，又一座采用申菱中央空调解决方案的大型场馆项目正...
09-01 15:27
股价回调20%创造买入良机 礼来(LLY.US)未来或将跻身“万亿美元俱乐部”
过去30天里，礼来股价回调幅度达20%。在分析人士看来，这为长期投资者创造了绝佳的逢低买入机会。
08-18 14:55
跨国药企半年报：冰火两重天，创新突围战打响
21世纪经济报道记者 季媛媛 韩利明 8月以来，包括强生、艾伯维、默沙东、罗氏、辉瑞、阿斯利康、诺华、百时美施贵宝、诺和诺德等在内的跨国药企均已公开2025年上...
08-12 14:06
Eli Lilly Co. Q2 FY2025 Earnings Transcript
Eli Lilly delivered a strong Q2 2025 with 38% revenue growth and major clinical milestones, despite a selloff over obesity drug trial data.
08-08 01:44
Verve Therapeutics Announces Merger and Nasdaq Delisting
Verve Therapeutics ( ($VERV) ) just unveiled an update. Verve Therapeutics has ...
07-26 04:51
Eli Lilly And Verve Therapeutics Announces That The Tender Offer For All Outstanding Verve Shares, Priced At $10.50 Per Share In Cash Plus A Potential Additional $3.00 Via A Non-Tradable Contingent Value Right, Officially Expired At 12:01 A.M. Et On July 24, 2025. The Offer Was Not Extended.
Eli Lilly and Company (NYSE:LLY) and Verve Therapeutics, Inc. (NASDAQ:VERV) today announced that the tender offer to purchase all of the issued and outstanding shares ("Shares") of Verve's common stock in exchange for
07-24 20:05
Verve Therapeutics Announces Retention Bonus Program for Executives
Verve Therapeutics ( ($VERV) ) has shared an announcement. Verve Therapeutics a...
07-15 18:45
200%税率威胁下 这一美国关税“高危”行业为何还能涨？
①当一位美国总统威胁要对你的行业征收200%的关税时，这通常不是什么好消息； ②然而，自上周二美国总统特朗普在内阁会议上表示将对进口药品征收巨额关税以来，该行业的高管和投资者们，却似乎并没有流露出过多恐慌的情绪……
07-14 11:26
Trump Threatens 200% Pharma Tariffs, But Analyst Says This Stock Is Immune And Expected To 'Benefit' From Levies
Donald Trump's proposed 200% tariffs can squeeze the profit margins of pharma companies, but LLY is poised to "benefit" except for the rest.
07-11 19:57
